Potential Sunitinib-Induced Coronary Artery and Aortic Dissections

被引：13
|
作者：
Hatem, Raja [1 ]
Bebawi, Emmanuel [1 ]
Schampaert, Erick [1 ]
机构：
[1] Univ Montreal, Hop Sacre Coeur Montreal, Cardiol Dept, 5400 Blvd Gouin Ouest, Montreal, PQ H4J 1C5, Canada
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2017年 / 33卷 / 06期
关键词：
D O I：
10.1016/j.cjca.2017.03.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Small-molecule multitargeted tyrosine kinase inhibitor (TKI) therapy is used in different types of cancer. These drugs have been associated with cardiovascular toxicity, including aortic dissection. To our knowledge, this is the first time that a coronary dissection potentially associated with a TKI treatment has been described.
引用
收藏
页码：830.e17 / 830.e18
页数：2
相关论文
共 50 条
  • [31] Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity
    van Erp, Nielka P.
    Eechoute, Karel
    van der Veldt, Astrid A.
    Haanen, John B.
    Reyners, An K. L.
    Mathijssen, Ron H. J.
    Boven, Epie
    van der Straaten, Tahar
    Baak-Pablo, Renee F.
    Wessels, Judith A. M.
    Guchelaar, Henk-Jan
    Gelderblom, Hans
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4406 - 4412
  • [32] Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity
    van Erp, N.
    Mathijssen, R. H.
    van der Veldt, A. A.
    Haanen, J. B.
    Reyners, A. K.
    Eechoute, K.
    Boven, E.
    Wessels, J. A.
    Guchelaar, H.
    Gelderblom, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Sunitinib-Induced Hypothyroidism and Survival in Pancreatic Neuroendocrine Tumors
    Mathew, Annie
    Fuhrer, Dagmar
    Lahner, Harald
    HORMONE AND METABOLIC RESEARCH, 2021, 53 (12) : 794 - 800
  • [34] Sunitinib-induced hypothyroidism in patients with gastrointestinal stromal tumors
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (3): : 205 - 205
  • [35] Role of endoplasmic reticulum stress in sunitinib-induced hepatotoxicity
    Arzuk, E.
    TOXICOLOGY LETTERS, 2024, 399 : S204 - S204
  • [36] Unanswered questions regarding the management of sunitinib-induced hypothyroidism
    Garfield, David
    Hercbergs, Aleck
    Davis, Paul
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (12): : 674 - 675
  • [37] Sunitinib-Induced Hemoglobin Changes Are Related to the Dosing Schedule
    van der Veldt, Astrid A. M.
    Boven, Epie
    Vroling, Laura
    Broxterman, Henk J.
    van den Eertwegh, Alfons J. M.
    Haanen, John G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1339 - 1340
  • [38] Sunitinib-Induced Acute Liver Failure: A Case Presentation
    Aqsa, Anum
    Droubi, Sami
    Amarnath, Shivantha
    Al Moussawi, Hassan
    Abergel, Jeffrey R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1278 - S1278
  • [39] Sunitinib-induced nephrotic syndrome and irreversible renal dysfunction
    Takahashi, Daiei
    Nagahama, Kiyotaka
    Tsuura, Yukio
    Tanaka, Hiroyuki
    Tamura, Teiichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (02) : 310 - 315
  • [40] Case of sunitinib-induced Stevens-Johnson syndrome
    Lee, Joo Hee
    Lee, Ji Hye
    Lee, Ji Hyun
    Kim, Si Y.
    Kim, Gyong Moon
    JOURNAL OF DERMATOLOGY, 2013, 40 (09): : 753 - +
12345